Literature DB >> 25773794

Liver cancer mortality characteristics and trends in China from 1991 to 2012.

Jia-Ying Fang1, Ku-Sheng Wu, Yang Zeng, Wen-Rui Tang, Pei-Ling Du, Zhen-Xi Xu, Xiao-Ling Xu, Jia-Yi Luo, Kun Lin.   

Abstract

PURPOSE: To investigate the distribution of liver cancer mortality as well as its developing trend from l991 to 2012, forecast the future five-year trend, and provide a basis for the comprehensive prevention and management.
MATERIALS AND METHODS: Mortality data for liver cancer in China from 1991 to 2012 were used to describe characteristics and distribution of liver cancer mortality. Trend surface analysis was used to study the geographical distribution of liver cancer mortality. Curve estimation, time series modeling, gray modeling (GM) and joinpoint regression were used to predict and forecast future trends.
RESULTS: The mortality rate of liver cancer has constantly increased in China since 1991. Rates in rural areas are higher than in urban areas, and in males are higher than in females. In addition, our data predicted that the trend will continue to increase in the next 5 years. The age-specific mortality of liver cancer increases with age and peaks in the group of 80-84 years old. Geographical analysis showed the liver mortality rate was higher in the southeast provinces, such as Jiangsu, Zhejiang and Guangdong, and southwest regions like Guangxi Province.
CONCLUSIONS: The standardized mortality rate of liver cancer in China has consistently increased from 1991 to 2012, and the upward trend is predicted to continue in the future. Much better prevention and management of liver cancer is needed in high mortality areas (the southwestern and southeastern parts of China) and high mortality age groups (80- to 84-year-olds), especially in rural areas.

Entities:  

Mesh:

Year:  2015        PMID: 25773794     DOI: 10.7314/apjcp.2015.16.5.1959

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  8 in total

1.  The Association between Dietary Vitamin A and Carotenes and the Risk of Primary Liver Cancer: A Case-Control Study.

Authors:  Qiu-Ye Lan; Yao-Jun Zhang; Gong-Cheng Liao; Rui-Fen Zhou; Zhong-Guo Zhou; Yu-Ming Chen; Hui-Lian Zhu
Journal:  Nutrients       Date:  2016-10-11       Impact factor: 5.717

2.  ESTABLISHMENT AND EVALUATION OF ORTHOTOPIC HEPATOCELLULAR CARCINOMA AND DRUG-INDUCED HEPATOCELLULAR CARCINOMA IN MICE WITH SPLEEN-DEFICIENCY SYNDROME IN TRADITIONAL CHINESE MEDICINE.

Authors:  Haoxuan Luo; Yan Chen; Baoguo Sun; Ting Xiang; Shijun Zhang
Journal:  Afr J Tradit Complement Altern Med       Date:  2016-11-23

3.  Synthesis of hydroxycinnamic acid derivatives as mitochondria-targeted antioxidants and cytotoxic agents.

Authors:  Jiyu Li; Dian He; Baitao Wang; Ling Zhang; Kun Li; Qinjian Xie; Lifang Zheng
Journal:  Acta Pharm Sin B       Date:  2016-06-02       Impact factor: 11.413

4.  Integrated analysis of the impact of age on genetic and clinical aspects of hepatocellular carcinoma.

Authors:  Manar Atyah; Yi-Rui Yin; Chen-Hao Zhou; Qiang Zhou; Wan-Yong Chen; Qiong-Zhu Dong; Ning Ren
Journal:  Aging (Albany NY)       Date:  2018-08-20       Impact factor: 5.682

5.  Epidermal growth factor-containing fibulin-like extracellular matrix protein 1 (EFEMP1) suppressed the growth of hepatocellular carcinoma cells by promoting Semaphorin 3B(SEMA3B).

Authors:  Jiangfeng Hu; Bensong Duan; Weiliang Jiang; Sengwang Fu; Hengjun Gao; Lungen Lu
Journal:  Cancer Med       Date:  2019-04-11       Impact factor: 4.452

6.  Spatial and temporal analysis of liver cancer mortality in Yunnan province, China, 2015-2019.

Authors:  Chengcheng Feng; Jinghua Liu; Hailiang Ran; Linxiong Wu; Xuemeng Liang; Hao Sun; Yuanyuan Xiao; Wei Chang
Journal:  Front Public Health       Date:  2022-09-27

7.  Population-Based Incidence, Mortality, And Survival For Gastrointestinal Cancers During 2006-2016 In Wuhan, Central China.

Authors:  Yao Cheng; Jianhua Liu; Qing Liao; Xuejiao Hu; Hongyan Lv; Peiyan Ding; Shaofa Nie; Li Tan
Journal:  Cancer Manag Res       Date:  2019-10-29       Impact factor: 3.989

8.  Overexpression of Klotho suppresses liver cancer progression and induces cell apoptosis by negatively regulating wnt/β-catenin signaling pathway.

Authors:  Huidong Sun; Yanchao Gao; Kemei Lu; Guimei Zhao; Xuehua Li; Zhu Li; Hong Chang
Journal:  World J Surg Oncol       Date:  2015-10-24       Impact factor: 2.754

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.